Bionic Sight Llc

This early-stage trial tests a gene therapy called BS01 for people with retinitis pigmentosa, a condition that causes gradual vision loss. The treatment uses a harmless virus to deliver a light-sensitive protein to cells in the eye, aiming to help them detect light again. About 2…

This study tests a new gene therapy called BS01 for people with advanced dry age-related macular degeneration (AMD) that causes blind spots. The treatment is given as an injection into the eye and aims to slow or stop further vision loss. The trial involves 40 adults aged 50 to 8…